Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
BLFS
$37.30
+1.41%
BLFS
· Biolife Solutions Inc
$37.30
+0.52 (+1.41%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$1.92B
Shares
48.91M
Volume · Oct 2
2.85M
Avg daily vol (3M)
1.07M
All webcasts
Earnings call · FY2024 Q2
Biolife Solutions Inc (BLFS) Q2 2024 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$19.71M
-32.6% YoY
Diluted EPS
-$0.45
Net income
-$20.72M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 8, 2024.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Cell Processing platform revenue
Initiated
full-year 2024
|
$70M – $71M | — |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 8, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 9, 2024 · complete as-filed document